… GVHD on leukemia-free survival be evaluated [ 101. In … mixed chimerism is converted to
complete donor type chimerism after … for chronic myeloid leukemia: is T cell dose important in …

… before allogeneic blood or marrow transplantation. … residual disease and chimerism in
patients with chronic myeloid … sibling donors in patients with first chronic phase chronic myeloid …

… period had been limited to chronic myeloid leukemia (CML), with … by donor lymphocyte
infusion for many years. In AML, … hematopoietic chimerism after bone marrow transplantation …

… In 2021, the European Blood and Marrow Transplantation (… F and G Comparison of donor
chimerism measured by NGS … of overt relapse, relapse-free survival, and overall survival by …

… defined as the minimum time to relapse, death, or last follow-up. For all … or blood as detected
by a chimerism assay. … Bone marrow transplantation for chronic myelogenous leukemia in …

… Chimerism is a measure of the number of donor and recipient … had myeloid diseases, including
acute myeloid leukemia in 17 … relapse or death or last follow-up for disease-free survival (…

… on disease recurrence in patients with acute myeloid leukemia (AML) … rate of disease
recurrence, progression free survival was … We found that CD3 chimerism form the haplo-donor was …

… remission of relapsed chronic myelogenous leukemia (CML) after … Overall survival and
progression-free survival rates were … of donor T cell chimerism at the time of pDLI as a predictor of …

… The 4-year disease-free survival (DFS) and overall survival (… , this variable was also the
strongest predictor for 4-year OS … donor chimerism and an earlier GvL effect, despite severe …

… to IV acute GVHD-free, graft-failure-free survival was 80% at … Split chimerism, with donor T
cell chimerism markedly lower … part of the disease phenotype and indication for transplant, for …